Test Price
2,800 AED✅ Home Collection Available
DSC2 Gene Genetic Testing for ARVC Type 11 in Dubai, UAE – 2800 AED – DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified sequencing targeted to DSC2 exon and intron regions.
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection (daily 8 AM – 11 PM) for peripheral whole blood or FTA card.
- Clinical Guidance: Complimentary post-test telephone consultation with a DHA‑licensed consultant medical geneticist for result interpretation and family cascade screening advice.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The DSC2 gene test screens for pathogenic variants associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 11 (ARVC‑11), a heritable heart muscle disorder that can cause life‑threatening arrhythmias. Our targeted Next‑Generation Sequencing (NGS) delivers higher diagnostic yield than broad panels by focusing exclusively on the DSC2 gene with deep coverage including intronic and regulatory regions.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Generic Panel) |
|---|---|---|
| Methodology | NGS – DSC2 Single Gene Full Sequencing & CNV Analysis | Multi‑gene NGS Panel (30–80 genes) |
| Diagnostic Precision | 99.9% sensitivity for DSC2 variants; ISO‑validated | Variable coverage; often miss deep intronic/regulatory variants |
| Turnaround Time | 3–4 weeks | 4–8 weeks |
| Price (AED) | 2,800 | 2,200 – 4,500 |
Physician Insight & Safety Protocols
“A positive DSC2 variant increases susceptibility to ARVC but does not confirm disease. Interpretation must integrate ECG, Holter, and cardiac MRI findings. Negative results do not exclude other genetic cardiomyopathies; comprehensive genetic counselling is essential for every patient.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Medication Advisory
Do not discontinue any prescribed cardiac medication (e.g., beta‑blockers, antiarrhythmics) without consulting your treating physician. This genetic test does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Not suitable for individuals with an implantable device that prohibits phlebotomy or those unable to provide informed consent.
- Exclusion: This test cannot be used as a sole tool for emergency diagnosis; it complements but does not replace cardiac imaging (Echo, MRI).
- ER Red Flags — Seek Immediate Medical Attention If You Experience: Sudden chest pain, palpitations with dizziness, fainting (syncope) or near‑fainting episodes, severe shortness of breath.
- If the patient is a minor, written parental/guardian consent is required before sample collection, and mandatory post‑test genetic counselling must be completed.
Patient FAQ & Clinical Guidance
1. What does a positive DSC2 mutation mean for my health?
A positive DSC2 mutation indicates an increased genetic susceptibility to arrhythmogenic right ventricular cardiomyopathy, not a definitive disease state. It must be correlated with a comprehensive cardiac evaluation including ECG, Holter monitoring, and cardiac MRI. Family cascade screening is recommended.
2. How do I prepare for the DSC2 genetic test and what is the procedure?
A mandatory pre‑test genetic counselling session will collect your three‑generation family history and draw a pedigree chart before sample collection. On the day, our DHA‑licensed phlebotomist will collect a blood sample (or DNA via FTA card) from your home. No fasting is required. The sample is transported in an ISO‑certified cold chain to our genomics lab.
3. Is my genetic data protected under UAE law and can insurance cover this test?
Yes, your data is secured in compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 on Health Data Protection. All genetic information is encrypted and stored exclusively within the UAE. Many insurance plans cover genetic testing when medically indicated; our team will verify your coverage directly via WhatsApp (+971 54 548 8731) and handle pre‑approvals.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields. All genetic data is encrypted, stored on local UAE servers, and never shared without explicit patient consent. Medical liability is governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your rights to access, rectification, and deletion of personal data are fully protected.
Clinical & Logistical Metadata
| Test Name | DSC2 Gene Sequencing (ARVC Type 11) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – DSC2 single gene, full coding & intronic coverage, CNV detection |
| ICD-10-CM Code | I42.8 |
| LOINC Code | 85838-9 |
| DHA Facility License & Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians